OPKO Health
OPK
#5956
Rank
ยฃ0.81 B
Marketcap
ยฃ1.08
Share price
0.70%
Change (1 day)
5.71%
Change (1 year)

P/E ratio for OPKO Health (OPK)

P/E ratio as of June 2026 (TTM): -5.96

According to OPKO Health 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -5.95833. At the end of 2024 the company had a P/E ratio of -21.0.

P/E ratio history for OPKO Health from 2001 to 2025

PE ratio at the end of each year

Year P/E ratio Change
2024-21.0247.68%
2023-6.04112.61%
2022-2.84-97.05%
2021-96.2-221.77%
202079.0-2948.3%
2019-2.77-75.12%
2018-11.120.58%
2017-9.25-96.02%
2016-233101.42%
2015-115362.19%
2014-25.0

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Johnson & Johnson
JNJ
26.6-546.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
25.1-520.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
14.4-341.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
15.6-361.98%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
23.1-487.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
77.1-1,393.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
24.3-507.45%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Ardelyx
ARDX
-24.1 304.26%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.